Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
Telomerase inhibitor
DRUG CLASS:
Telomerase inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
tretinoin (6)
BIBR1532 (1)
sodium metaarsenite (1)
tertomotide (1)
THIO (0)
GX301 (0)
suratadenoturev (0)
VAC2 (0)
bisantrene (0)
GRN163L (0)
tretinoin (6)
BIBR1532 (1)
sodium metaarsenite (1)
tertomotide (1)
THIO (0)
GX301 (0)
suratadenoturev (0)
VAC2 (0)
bisantrene (0)
GRN163L (0)
›
Associations
(9)
News
Trials
Search handles
@Dr_AmerZeidan
@hemedoc
@smbenlazar
Search handles
@Dr_AmerZeidan
@hemedoc
@smbenlazar
Filter by
Latest
10ms
Einige Personen mit myelodysplastischem Syndrom profitieren von #Imetelstat. Im Vergleich zu Placebo konnte die Zeit ohne Transfusionen signifikant verlängert werden – bei 17,8% der Verumgruppe sogar bis zu einem Jahr oder länger. #EHA23 #Krebs https://t.co/HDjus7dfNG (Reg.) (@SpringerMedizin)
10 months ago
Clinical
|
imetelstat (GRN163L)
10ms
Amer Methqal Zeidan, MBBS, MHS, on Myelodysplastic Syndromes: New Data From the IMerge Study of Imetelstat https://t.co/XHF9l9wlN0 #MDS #hematology @Dr_AmerZeidan @Yale @YaleCancer (@ASCOPost)
10 months ago
imetelstat (GRN163L)
11ms
Imetelstat Displays Significant Efficacy in R/R Myelodysplastic Syndrome https://t.co/v6kR8uKMsx via @targetedonc (@Dr_AmerZeidan)
11 months ago
Clinical
|
imetelstat (GRN163L)
11ms
First author @Dr_AmerZeidan presents results of the Phase III study #IMerge today at 2:12pm CDT during the Hematologic Malignancies track. https://t.co/FSpNJbOcTP #ASCO23 #hematology #imetelstat @YaleHematology @SmilowCancer @YaleMed @YNHH @OncoAlert (@YaleCancer)
11 months ago
imetelstat (GRN163L)
11ms
.@Dr_AmerZeidan shared that Imetelstat helped 1/3 of patients with lower-risk myelodysplastic syndromes achieve complete transfusion independence. #ASCO23 #MDSsm #IMerge @ASCO @YaleHematology @SmilowCancer @YaleMed @YNHH @OncoAlert https://t.co/yWm7YLCcDi (@YaleCancer)
11 months ago
Clinical
|
imetelstat (GRN163L)
11ms
#ASCO23 #leusm #mdssm Patel: these two positive studies w luspatercept and Imetelstat in LR-MDS are groundbreaking for both frontline and second line therapy. (@hemedoc)
11 months ago
Clinical
|
Reblozyl (luspatercept-aamt) • imetelstat (GRN163L)
11ms
@ASCO is coming up next week! @MirzaCPH will present: A randomized trial of olaparib, durvalumab, and #cancervaccine, UV1, as maintenance therapy in patients with BRCAwt with recurrent #ovariancancer: ENGOT-OV56/NSGO-CTU-DOVACC trial #phase2 #immunotherapy https://t.co/9YWK7m4cHZ (@ultimovacs)
11 months ago
Clinical
|
Lynparza (olaparib) • Imfinzi (durvalumab) • UV1
11ms
CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3 https://t.co/evy95MaqUe #MDS #EHA23 (@smbenlazar)
11 months ago
imetelstat (GRN163L)
11ms
Title: DISEASE MODIFYING ACTIVITY OF IMETELSTAT IN PATIENTS WITH HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS #MDS #EHA23 EHA Library; Jun 08 2023; 387864 https://t.co/DStUd4ziRg (@smbenlazar)
11 months ago
Clinical
|
imetelstat (GRN163L)
over4years
"Now...time for @JNJNews and @JanssenUS to take another look at $GERN and #Imetelstat... #GERON #JNJ @JNJCares @JNJVision" (@TMAN1138pm)
over 4 years ago
imetelstat (GRN163L)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login